143 related articles for article (PubMed ID: 3131471)
1. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Sadoff JC; Ohman D; Fürer E
J Lab Clin Med; 1988 Jun; 111(6):701-7. PubMed ID: 3131471
[TBL] [Abstract][Full Text] [Related]
2. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
Cryz SJ; Cross AS; Sadoff GC; Que JU
Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
Cryz SJ; Fürer E; Cross AS; Wegmann A; Germanier R; Sadoff JC
J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.
Cryz SJ; Sadoff JC; Fürer E
Infect Immun; 1988 Jul; 56(7):1829-30. PubMed ID: 2454893
[TBL] [Abstract][Full Text] [Related]
5. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
6. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
Pier GB; Thomas DM
J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
[TBL] [Abstract][Full Text] [Related]
8. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.
Rosenqvist E; Høiby EA; Bjune G; Bryn K; Closs O; Feiring B; Klem A; Nøkleby H; Frølm LO
NIPH Ann; 1991 Dec; 14(2):169-79; discussion 180-1. PubMed ID: 1687481
[TBL] [Abstract][Full Text] [Related]
9. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
10. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
[TBL] [Abstract][Full Text] [Related]
12. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide.
Shackelford PG; Granoff DM; Nelson SJ; Scott MG; Smith DS; Nahm MH
J Immunol; 1987 Jan; 138(2):587-92. PubMed ID: 3491852
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
14. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
[TBL] [Abstract][Full Text] [Related]
15. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Sadoff JC; Fürer E
Microb Pathog; 1989 Jan; 6(1):75-80. PubMed ID: 2733597
[TBL] [Abstract][Full Text] [Related]
16. IgG subclass composition of the antibody response of healthy adults, and normal or IgG2-deficient children to immunization with H. influenzae type b polysaccharide vaccine or Hib PS-protein conjugate vaccines.
Shackelford PG; Granoff DM
Monogr Allergy; 1988; 23():269-81. PubMed ID: 3260337
[No Abstract] [Full Text] [Related]
17. Post-immunization pneumococcal antibody titers and IgG subclasses.
Sorensen RU; Hidalgo H; Moore C; Leiva LE
Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
[TBL] [Abstract][Full Text] [Related]
18. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
Meitert T; Meitert E; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
[No Abstract] [Full Text] [Related]
19. Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans.
Cryz SJ; Sadoff JC; Cross AS; Fürer E
Antibiot Chemother (1971); 1989; 42():177-83. PubMed ID: 2512836
[No Abstract] [Full Text] [Related]
20. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
